Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Accounts Payables (2016 - 2025)

OptimizeRx (OPRX) has disclosed Accounts Payables for 16 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 24.12% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, down 24.12% year-over-year, with the annual reading at $1.6 million for FY2025, 24.12% down from the prior year.
  • Accounts Payables hit $1.6 million in Q4 2025 for OptimizeRx, down from $2.0 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $3.4 million in Q1 2025 to a low of $499279.0 in Q1 2021.
  • Historically, Accounts Payables has averaged $1.5 million across 5 years, with a median of $1.4 million in 2022.
  • Biggest five-year swings in Accounts Payables: crashed 36.9% in 2023 and later skyrocketed 298.46% in 2024.
  • Year by year, Accounts Payables stood at $606808.0 in 2021, then soared by 155.43% to $1.5 million in 2022, then soared by 43.68% to $2.2 million in 2023, then decreased by 3.19% to $2.2 million in 2024, then decreased by 24.12% to $1.6 million in 2025.
  • Business Quant data shows Accounts Payables for OPRX at $1.6 million in Q4 2025, $2.0 million in Q3 2025, and $2.0 million in Q2 2025.